Background and aims: The role of the Papanicolou (Pap) smear in the early detection and
| INTRODUCTION
Despite the established place of Papanicolou (Pap) smears in the prevention and early detection of cervical cancer, uptake of national cervical cytology programs remains a concern (the 2-year participation rate for the National Cervical Screening Program [NCSP] in [2009] [2010] was 57.4% of women in the target age group). 1, 2 Reasons given by women for failing to attend for smears conducted by practitioners include embarrassment, 3 physical discomfort, 4 the invasive nature of the pelvic examination, inconvenience, and, in remote communities, personal associations with the health practitioner. [5] [6] [7] To overcome these barriers, a more acceptable method of cervical screening is needed. Studies have previously shown that in other settings, self-sampling is associated with better participation rates in screening programs [8] [9] [10] [11] [12] and lower levels of dissatisfaction.
Current National Health and Medical Research Council guidelines 13,14 continue to recommend cervical cytology as the pri-the sample was collected by introducing a cervibroom into the endocervix. The self-collected and the physician-collected specimens were sent for analysis to the same laboratory on the day of collection.
A pathologist, blinded to the method of collection, reviewed the cervical cytology. The results of the cervical cytology collected, and both reports, were reviewed by the investigators following the review, to ascertain the extent of agreement or disagreement between the results of the patient-collected Pap smear with that collected by the clinician. Squamous abnormalities were classified according to the Australian modified Bethesda AMBS 2004 into the following 4 categories:
"negative," "low grade squamous intraepithelial lesion" (LSIL), "high grade squamous intraepithelial lesion" (HSIL), and "squamous carcinoma." Any abnormality confirmed by colposcopy was managed according to NHRMC Guidelines.
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Pairwise agreement between the numbers of abnormalities identified by self-collected, colposcopic, and clinician-collected samples, and 95% confidence intervals were computed. Chance-corrected agreement was assessed by weighted κ statistics. 24 A κ value of above 0.8 was taken to indicate "very good agreement"; between 0.6 and 0.8, "reasonable agreement"; 0.4 and 0.6, "moderate agreement"; 0.2 and 0.4, "fair agreement"; and less than 0.2, "poor agreement." 25 Calculations were performed using SAS version 9.3.
| RESULTS
A total of 40 women participated in the study. Table 1 , and pairwise comparisons are presented in Table 2 . Importantly, no high-grade abnormality identified from clinician-collected or colposcopic samples was missed by the self-collected sampling.
The overall agreement between detection of any abnormality of the self-collected Pap smear with that collected by a clinician was "fair" Abbreviations: HSIL, high-grade squamous intraepithelial lesion; LSIL, lowgrade squamous intraepithelial lesion.
In the past, cervical sampling was considered adequate if endocervical cells were detected; however, a definition of "adequate sample" remains elusive. More recent research has shown that the absence of endocervical cells is not necessarily associated with a higher risk of cervical abnormality. [26] [27] [28] [29] [30] [31] [32] In our study, endocervical component was detected in 15% of self-collected Pap smears and in 94% of clinician-collected smears, a difference that was statistically significant (P < .05). 34 Conventional cervical cytology screening, therefore, remains the primary method of detection of cervical cancer. 9, 13 Despite the successes, significant deficiencies in the system remain. In 2009 and 2010, the participation rate 13 in the NCSP was only 57%. The incidence of cervical cancer in Indigenous Australian and Torres Strait Islander women was more than twice that of nonindigenous women, and mortality of Indigenous and Torres Straight
Islander women was 5 times the rate for nonindigenous women. 2 While geographic location was not a significant variable, participation rates varied markedly across socioeconomic groups, ranging from 52% among women from low socioeconomic to 63% in higher socioeconomic areas.
2,13
The proven effectiveness of the cervical screening smear program, combined with the nonparticipation rate of around 40%, suggests the need for novel methods to increase screening coverage. 7 This study suggests that self-sampling might have a role to play in this process. 3 All the participants in this study found the technique of self-sampling acceptable, comfortable, and easy to learn. Many women may prefer a test that can be performed by the woman herself, if necessary in the privacy of her own home. 3-6,9,22 Self-sampling may also obviate known obstacles to participation in screening, such as embarrassment or discomfort within the clinical relationships.
For our study, we used cervibroom, a standard brush used in gynecology clinics. There have been few other devices like solopap, dacronswabs, and digene conical collection used for this test as well. 19, 20, 35, 36 The cervibroom is already used for pap smears and comes at no extra cost; it is also easy to use. The most important difference is that with cervibroom-collected samples, a liquid-based cytology slide can be made if required. All of these facts make it potentially a better device to use. It is also true that the difference in HPV prevalence between the self-collected and clinician-collected sampling was not significantly different from 0, regardless of the sampling devices and diagnostic methods used. 19 Our findings show that the agreement of the results of self-sampling with the gold standard of colposcopically guided sampling is no worse than that of physician sampling. In addition, the specificity for the detection of abnormalities of self-sampling and clinician sampling are very similar. Accordingly-at least in the cases of women otherwise disinclined to undergo sampling at all-self-sampling would seem to be an acceptable and effective alternative that might be recommended. This technique might offer an effective alternative approach for at least some of the women who do not presently comply with the NCSP. The single significant difference between the 2 techniques-the lower presence of endocervical cells in the self-collected samples-is a potential cause for concern, because it suggests that many of these samples might not have included cells from the transformation zones.
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